Thrivent Financial for Lutherans’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$319M Sell
1,305,102
-263,842
-17% -$61.5M 0.61% 20
2025
Q4
$325M Sell
1,568,944
-204,930
-12% -$40.5M 0.58% 18
2025
Q3
$329M Buy
1,773,874
+263,667
+17% +$45.2M 0.65% 18
2025
Q2
$231M Buy
1,510,207
+40,239
+3% +$6.19M 0.5% 24
2025
Q1
$243M Sell
1,469,968
-30,349
-2% -$4.75M 0.54% 22
2024
Q4
$217M Sell
1,500,317
-55,395
-4% -$8.58M 0.42% 30
2024
Q3
$252M Sell
1,555,712
-79,151
-5% -$12.6M 0.48% 24
2024
Q2
$239M Buy
1,634,863
+394,518
+32% +$58.7M 0.48% 22
2024
Q1
$196M Buy
1,240,345
+331,299
+36% +$52.7M 0.39% 39
2023
Q4
$142M Sell
909,046
-31,373
-3% -$4.81M 0.31% 66
2023
Q3
$146M Sell
940,419
-339,529
-27% -$56M 0.35% 58
2023
Q2
$212M Buy
1,279,948
+105,214
+9% +$17M 0.48% 22
2023
Q1
$182M Sell
1,174,734
-37,806
-3% -$6.1M 0.44% 33
2022
Q4
$214M Sell
1,212,540
-227,622
-16% -$39.3M 0.55% 20
2022
Q3
$235M Buy
1,440,162
+71,541
+5% +$12.1M 0.65% 12
2022
Q2
$243M Sell
1,368,621
-87,249
-6% -$15.5M 0.65% 13
2022
Q1
$258M Buy
1,455,870
+39,780
+3% +$6.77M 0.5% 27
2021
Q4
$242M Buy
1,416,090
+43,053
+3% +$7.05M 0.47% 33
2021
Q3
$222M Buy
1,373,037
+28,404
+2% +$4.85M 0.45% 36
2021
Q2
$222M Buy
1,344,633
+25,694
+2% +$4.25M 0.45% 34
2021
Q1
$217M Sell
1,318,939
-127,403
-9% -$20.6M 0.48% 31
2020
Q4
$228M Sell
1,446,342
-65,327
-4% -$9.64M 0.53% 26
2020
Q3
$225M Sell
1,511,669
-8,374
-0.6% -$1.24M 0.6% 19
2020
Q2
$213M Sell
1,520,043
-10,498
-0.7% -$1.53M 0.64% 16
2020
Q1
$201M Sell
1,530,541
-19,691
-1% -$2.79M 0.72% 17
2019
Q4
$226M Buy
1,550,232
+3,995
+0.3% +$542K 0.64% 21
2019
Q3
$200M Sell
1,546,237
-45,707
-3% -$6.02M 0.62% 24
2019
Q2
$222M Buy
1,591,944
+28,592
+2% +$3.96M 0.67% 21
2019
Q1
$219M Buy
1,563,352
+9,727
+0.6% +$1.3M 0.69% 24
2018
Q4
$201M Buy
1,553,625
+371,404
+31% +$51.8M 0.72% 23
2018
Q3
$163M Sell
1,182,221
-51,174
-4% -$6.8M 0.51% 37
2018
Q2
$150M Buy
1,233,395
+10,441
+0.9% +$1.3M 0.49% 40
2018
Q1
$157M Buy
1,222,954
+679,618
+125% +$91.9M 0.53% 41
2017
Q4
$75.9M Buy
543,336
+15,161
+3% +$2.11M 0.25% 85
2017
Q3
$68.7M Buy
528,175
+8,413
+2% +$1.12M 0.24% 102
2017
Q2
$68.8M Buy
519,762
+12,381
+2% +$1.58M 0.29% 88
2017
Q1
$63.2M Sell
507,381
-25,820
-5% -$3.08M 0.27% 89
2016
Q4
$61.4M Buy
533,201
+388,050
+267% +$44.8M 0.27% 96
2016
Q3
$17.2M Buy
145,151
+4,473
+3% +$543K 0.08% 260
2016
Q2
$17.1M Sell
140,678
-4,195
-3% -$477K 0.08% 245
2016
Q1
$15.7M Sell
144,873
-47,798
-25% -$4.95M 0.08% 248
2015
Q4
$19.8M Buy
192,671
+29,981
+18% +$3.02M 0.1% 209
2015
Q3
$15.2M Sell
162,690
-781,581
-83% -$75.6M 0.08% 239
2015
Q2
$92M Sell
944,271
-78,670
-8% -$7.88M 0.51% 46
2015
Q1
$103M Sell
1,022,941
-1,022,645
-50% -$104M 0.57% 41
2014
Q4
$214M Sell
2,045,586
-139,005
-6% -$14.6M 1.19% 6
2014
Q3
$233M Sell
2,184,591
-238,450
-10% -$24.7M 1.34% 4
2014
Q2
$253M Buy
2,423,041
+208,875
+9% +$21.1M 1.43% 3
2014
Q1
$217M Buy
2,214,166
+1,894,606
+593% +$176M 1.35% 5
2013
Q4
$29.3M Buy
319,560
+109,165
+52% +$10.1M 0.18% 129
2013
Q3
$18.2M Sell
210,395
-29,522
-12% -$2.65M 0.12% 199
2013
Q2
$20.6K Buy
+239,917
New +$20.4M 0.13% 175

Other funds holding JNJ

Thrivent Financial for Lutherans's JNJ Position: Q1 2026 in Review

Thrivent Financial for Lutherans reduced its Johnson & Johnson (JNJ) stake by 17% in Q1 2026, selling an estimated $61.5M and leaving 1,305,102 shares worth $319M. The position accounts for 0.61% of the portfolio, ranked #20.

Thrivent Financial for Lutherans first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. The position peaked at $329M in Q3 2025. 4,615 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Thrivent Financial for Lutherans held 1,305,102 shares of Johnson & Johnson worth $319M as of Q1 2026.
  • Thrivent Financial for Lutherans sold 263,842 Johnson & Johnson shares in Q1 2026, an estimated $61.5M.
  • Johnson & Johnson made up 0.61% of Thrivent Financial for Lutherans's portfolio in Q1 2026, its #20 holding.
  • Thrivent Financial for Lutherans first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • Thrivent Financial for Lutherans's Johnson & Johnson position peaked at $329M in Q3 2025.
  • 4,615 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Thrivent Financial for Lutherans's 13F filing for Q1 2026, filed 1 May 2026.